PK

Prashant Kumar Srivastava

Active Director Director DIN 08767180
DIN 08767180 First appointment Jun 2020 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Prashant Kumar Srivastava

Data last updated:

Prashant Kumar Srivastava is a Director at Golden Perch Pharmaceuticals Private Limited (since 2020). The company operates in Chemicals.

DIN 08767180
Primary Designation Director
Industry Chemicals
First Appointment 19 Jun 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Jun 20202020Active

Board colleagues of Prashant Kumar Srivastava

NameDINCompanyDesignation
Swati Srivastava08767181Golden Perch Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Golden Perch Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Prashant Kumar Srivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prashant Kumar Srivastava

Prashant Kumar Srivastava currently holds 1 directorship: Golden Perch Pharmaceuticals Private Limited (Director, since 19 Jun 2020).

Prashant Kumar Srivastava was first appointed on 19 Jun 2020 as Director at Golden Perch Pharmaceuticals Private Limited.

The current boards of Prashant Kumar Srivastava's companies include Swati Srivastava (Golden Perch Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available